Sequoia Sciences, Inc. Company Profile

00:23 EDT 20th March 2018 | BioPortfolio

Sequoia Sciences, an emerging leader in drug discovery, utilizes proprietary chemistry procedures and innovative technologies. Through internal research programs and collaborations with other drug discovery companies, our goal is to significantly increase the discovery rate of novel, drug-like compounds. On the basis of our current successes, we estimate that our rate of discovery of compounds with novel chemical structures will exceed 100 compounds annually.Sequoia’s proprietary methods and technologies are focused in the following areas:
1. Producing libraries of novel chemical compounds
2. Applying our advanced chemistry technologies for innovative uses
3. Discovering novel antibacterial compounds


1912 Innerbelt Business Center Drive
St. Louis
United States of America


Phone: 314-373-5181
Fax: 314-373-5186

News Articles [563 Associated News Articles listed on BioPortfolio]

UK's Vaccitech Raises $27 Million, Co-Led by Sequoia China

Vaccitech, an Oxford University spinout that is developing a universal flu vaccine along with other vaccine products, closed a $27 million Series A financing. The round was co-led by GV (formerly Goog...

Sequoia China devient un investisseur stratégique pour Income Partners Asset Management, ...

Le partenariat entre Income Partners et Sequoia China se définit par une synergie, une croissance rapide et une vision commune de la gestion des actifs Read more...

The Sequoia Project's Annual Meeting to Draw Health IT Leaders Nationwide to Discuss Data ...

VIENNA, VA--(Marketwired - Nov 16, 2017) - The Sequoia Project, the leading independent advocate for nationwide health data sharing, announced today that its annual Read more...

Sequoia Project Exec Appointed to HITAC’s Interoperability Task Force

Rajiv LeventhalThe Sequoia Project’s CIO/CTO, Eric Heflin, has been appointed to the Health Information Technology Advisory Committee’s (HITAC) U.S. Core Data for Interoperability Task Force (USCD...

Google Ventures and others back universal flu vaccine firm Vaccitech

Vector-based vaccine tech firm Vaccitech has secured Â20m ($27.1m) in venture capital with investors Google Ventures, Sequoia China, Neptune Ventures and Oxford Sciences Innovation.

AI Biotech Startup XtalPi Scores $15M From Google, Tencent and Sequoia

To date, XtalPi has raised over 20 million USD, making it one of the top-funded AI-powered biotechs.

Almac Sciences: Company Activity and Sharing Risks in Collaborations

In this episode of PharmaTelevision News Review, Fintan Walton talks with Denis Geffroy, Vice President Business Development at Almac Sciences at Almac. Filmed at BioTrinity 2010 in Newbury, UK, they ...

JW Therapeutics secures $90m in new funding

Clinical stage biopharmaceutical firm JW Therapeutics has secured $90m Series A financing from a consortium led by Temasek, Sequoia Capital China, and YuanMing Capital.

PubMed Articles [601 Associated PubMed Articles listed on BioPortfolio]

The function of Drosophila larval class IV dendritic arborization sensory neurons in the larval-pupal transition is separable from their function in mechanical nociception responses.

The sensory and physiological inputs which govern the larval-pupal transition in Drosophila, and the neuronal circuity that integrates them, are complex. Previous work from our laboratory identified a...

Acknowledgement to Reviewers of Veterinary Sciences in 2017.

Peer review is an essential part in the publication process, ensuring that Veterinary Sciences maintains high quality standards for its published papers[...].

Journal of Gerontology: Biological Sciences. A Long Tradition in Advancing Aging Biology and Translational Gerontology.

Sex and aging.

Women in biological sciences and medical research: let's break the glass ceiling!

Clinical Trials [172 Associated Clinical Trials listed on BioPortfolio]

M-learning to Improve Professional Competencies in Health Sciences

The aim of this study is to investigate whether a mobile application is useful for improving knowledge about professional competencies in students enrolled in Health Sciences degrees.

Cognitive Rehabilitation With C8 Sciences

C8 sciences program is a cognitive training program mainly developed for the students, and the effectiveness is well established. The aim of this trial is to assess clinical efficacy of th...

A Study of Sofosbuvir From Heterosofir 400 mg F.C.T (Pharmed Healthcare, Egypt) & Sovaldi 400 mg F.C.T ( Gilead Sciences, Ireland)

Comparative randomized, single dose, two-way crossover open-label study to determine the bioequivalence of Sofosbuvir from Heterosofir 400 mg F.C.T (Pharmed Healthcare Co., Egypt) versus S...

The Efficiency of CAMS (Chinese Academy of Medical Sciences)-2016 Trial for Pediatric Acute Myeloid Leukemia

The purpose of this study is to evaluate that whether the AML (acute myeloid leukemia)-CAMS (Chinese Academy of Medical Sciences)-2016 regimen, includes risk-stratified therapy and the use...

A Bio-equivalence Study of Sofosbuvir From Sofodelevier 400 mg Film Coated Tablets (Al-debeiky Pharma, Egypt) Versus Sovaldi 400 mg Tablets (Gilead Sciences, Canada)

Comparative randomized, single dose, three way three sequence two treatment partial replicate crossover open-label study to determine the bioequivalence of Sofosbuvir from Sofodelevier 400...

Companies [1048 Associated Companies listed on BioPortfolio]

Sequoia Sciences, Inc.

Sequoia Sciences, an emerging leader in drug discovery, utilizes proprietary chemistry procedures and innovative technologies. Through internal research programs and collaborations with other drug dis...

Sequoia Pharmaceuticals, Inc.

Sequoia Pharmaceuticals discovers and develops revolutionary new treatments for viral diseases including HIV/AIDS and HCV-induced hepatitis with a focus on the growing global problem of drug-resistant...

Sequoia Hospital

DVS Sciences, Inc.

DVS Sciences is a life sciences technology company that has developed and manufactures a novel technology for highly multiplexed analysis of single cells. DVS Sciences has an R&D ...

Cambridge Epigenetix

Cambridge Epigenetix’s mission is to improve health through the routine measurement of the epigenome. Cambridge Epigenetix utilizes innovative technologies, often based on fu...

More Information about "Sequoia Sciences, Inc." on BioPortfolio

We have published hundreds of Sequoia Sciences, Inc. news stories on BioPortfolio along with dozens of Sequoia Sciences, Inc. Clinical Trials and PubMed Articles about Sequoia Sciences, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Sequoia Sciences, Inc. Companies in our database. You can also find out about relevant Sequoia Sciences, Inc. Drugs and Medications on this site too.

Quick Search


Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Corporate Database Quicklinks

Searches Linking to this Company Record